[go: up one dir, main page]

ATE311928T1 - (-)-pseudoephedrin als sympathomimetisches arzneimittel - Google Patents

(-)-pseudoephedrin als sympathomimetisches arzneimittel

Info

Publication number
ATE311928T1
ATE311928T1 AT99959110T AT99959110T ATE311928T1 AT E311928 T1 ATE311928 T1 AT E311928T1 AT 99959110 T AT99959110 T AT 99959110T AT 99959110 T AT99959110 T AT 99959110T AT E311928 T1 ATE311928 T1 AT E311928T1
Authority
AT
Austria
Prior art keywords
pseudoephedrine
present
free
substantially free
sympathomimetic drug
Prior art date
Application number
AT99959110T
Other languages
English (en)
Inventor
Anthony R Booth
William Sherman
Peter Raven
James L Caffrey
Thomas Yorio
Michael Forster
Patricia Gwirtz
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE311928T1 publication Critical patent/ATE311928T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99959110T 1998-07-01 1999-06-08 (-)-pseudoephedrin als sympathomimetisches arzneimittel ATE311928T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9145198P 1998-07-01 1998-07-01
PCT/US1999/012692 WO2000001379A1 (en) 1998-07-01 1999-06-08 (-)-pseudoephedrine as a sympathomimetic drug

Publications (1)

Publication Number Publication Date
ATE311928T1 true ATE311928T1 (de) 2005-12-15

Family

ID=22227855

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99959110T ATE311928T1 (de) 1998-07-01 1999-06-08 (-)-pseudoephedrin als sympathomimetisches arzneimittel

Country Status (8)

Country Link
US (1) US6495529B1 (de)
EP (1) EP1091733B1 (de)
AT (1) ATE311928T1 (de)
AU (1) AU772807B2 (de)
DE (1) DE69928806T2 (de)
DK (1) DK1091733T3 (de)
ES (1) ES2251246T3 (de)
WO (1) WO2000001379A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7619005B2 (en) 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030232890A1 (en) 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
CA2427388C (en) * 2000-11-01 2011-12-20 Sention, Inc. Pharmaceutical compositions and uses for improving memory and learning impairments
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
WO2004010894A2 (en) 2002-07-30 2004-02-05 Omeros Corporation Ophthalmologic irrigation solutions and method
AU2016201834A1 (en) * 2002-07-30 2016-04-14 Omeros Corporation Ophthalmologic irrigation solutions and method
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US9238073B2 (en) 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
EP2488029B1 (de) 2009-09-30 2016-03-23 Acura Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur abschreckung vor missbrauch
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
MX392839B (es) 2012-11-30 2025-03-24 Acura Pharmaceuticals Inc Liberacion autorregulada de ingrediente farmaceutico activo.
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US11103581B2 (en) 2015-08-31 2021-08-31 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
JPH06506684A (ja) * 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物

Also Published As

Publication number Publication date
AU4335799A (en) 2000-01-24
EP1091733A1 (de) 2001-04-18
ES2251246T3 (es) 2006-04-16
DE69928806T2 (de) 2006-07-20
DK1091733T3 (da) 2006-04-03
AU772807B2 (en) 2004-05-06
WO2000001379A1 (en) 2000-01-13
EP1091733B1 (de) 2005-12-07
US6495529B1 (en) 2002-12-17
DE69928806D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
HRP20030046B1 (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
DE60027463D1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
WO2002041883A3 (en) As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
BR9607066A (pt) Método, composições e conjuntos para aumentar a biodisponibilidade oral de agentes farmacêuticos
NZ527113A (en) Rapid-onset medicament for the treatment of sexual dysfunction
NZ510887A (en) Formulations of fexofenadine for ocular and nasal delivery
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
ATE282418T1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
AR040709A1 (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion
NO20024646L (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
MX2021014161A (es) Metodos de tratamiento del sindrome de sjogren utilizando un inhibidor de la tirosina quinasa de bruton.
SE0102055D0 (sv) New Compounds
PT1187611E (pt) Composicoes oftalmicas de histamina e sua utilizacoes
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
SE9702066D0 (sv) A new salt
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
EA200300430A1 (ru) Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties